Loading clinical trials...
Loading clinical trials...
Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract
Conditions
Interventions
vinflunine and best supportive care
Locations
10
Canada
Local Institution
Calgary, Alberta, Canada
Local Institution
Edmonton, Alberta, Canada
Local Institution
Vancouver, British Columbia, Canada
Local Institution
Victoria, British Columbia, Canada
Local Institution
Brampton, Ontario, Canada
Local Institution
Hamilton, Ontario, Canada
Start Date
July 1, 2005
Primary Completion Date
January 1, 2008
Completion Date
January 1, 2008
Last Updated
January 7, 2010
NCT04235764
NCT00026884
NCT07061964
NCT03375307
NCT05316155
NCT04585750
Lead Sponsor
Pierre Fabre Medicament
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions